Hephaistos Pharma is a biotech company developing oncology treatments.
HEPHAISTOS-Pharma has raised $4.9M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
HEPHAISTOS-Pharma's investors include Bpifrance, Elaia, France 2030, EASME, EIC Accelerator.
HEPHAISTOS-Pharma is headquartered in Orsay, France.
Hephaistos Pharma is a biotech company developing oncology treatments.
HEPHAISTOS-Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HEPHAISTOS-Pharma — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/hephaistos-pharma. Accessed July 19, 2026.
VCBacked. (2024). HEPHAISTOS-Pharma — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/hephaistos-pharma
{{cite web |title=HEPHAISTOS-Pharma — Funding & Investors |url=https://www.vcbacked.co/company/hephaistos-pharma |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated